Novosis
-
Biologics
CGBio’s ‘NOVOSIS PUTTY’ Receives FDA ‘Breakthrough Device Designation,’ Accelerate Entry into the US Market
The first Korean developed medical device for spine implantation Expecte to receive faster approval in the U.S. by priority support…
Read More » -
Biologics
Orthofix Medical and CGBio Announce Strategic Partnership Agreement for Novosis rhBMP-2 Bone Graft Solutions
LEWISVILLE, Texas – August 2, 2022 /OrthoSpineNews/ — Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine…
Read More »